Benzinga

Benzinga

Benzinga

jueves, agosto 27

Matinas BioPharma Holdings Inc

MTNBAMEX
Trade with Public
Trade with Public
$0.1964
-0.0009-0.46%
al cierre: Aug 26, 5:00 PM EST
$0.1978
0.00140.71%
After hour: 7:15 PM EST
Panorámica generalNoticiasPrevisión de beneficiosPrecios objetivoFinanzasSentimientoPropiedadCompararInforme de acciones

Matinas BioPharma Hldgs Financials

Matinas BioPharma Hldgs (MTNB) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Matinas BioPharma Hldgs Q1 EPS $(0.30) Up From $(0.33) YoY

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.30) per share. This is a 9.09 percent increase over losses of $(0.33) per share from the same period last year.
Benzinga Newsdesk

PRO
Matinas BioPharma Hldgs Q4 EPS $(0.26) Up From $(1.68) YoY

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.26) per share. This is a 84.52 percent increase over losses of $(1.68) per share from the same period last year.
Benzinga Newsdesk

PRO
Matinas BioPharma Hldgs Q3 EPS $(0.40) Up From $(0.85) YoY

Matinas BioPharma Hldgs (AMEX:MTNB) reported quarterly losses of $(0.40) per share. This is a 52.94 percent increase over losses of $(0.85) per share from the same period last year.
Benzinga Newsdesk

Nasdaq Down 500 Points; Uber Shares Dip After Q3 Results

Avi Kapoor

Crude Oil Gains 1%; Meta Shares Fall Following Q3 Results

Avi Kapoor

Nasdaq Down Over 200 Points; Microsoft Shares Fall After Q1 Results

Avi Kapoor

Datos y APIs: APIs de Benzinga · API de noticias de acciones · API de calificaciones de analistas · API de logotipos de empresas

Benzinga

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL

© 2026 Benzinga | All Rights Reserved